Page last updated: 2024-09-03

sch 23982 and raclopride

sch 23982 has been researched along with raclopride in 2 studies

Compound Research Comparison

Studies
(sch 23982)
Trials
(sch 23982)
Recent Studies (post-2010)
(sch 23982)
Studies
(raclopride)
Trials
(raclopride)
Recent Studies (post-2010) (raclopride)
87001,802132419

Protein Interaction Comparison

ProteinTaxonomysch 23982 (IC50)raclopride (IC50)
D(2) dopamine receptorHomo sapiens (human)0.052
D(2) dopamine receptorMus musculus (house mouse)0.032
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0279

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coirini, H; Johnson, AE; Källström, L; Wiesel, FA; Yu, J1
Ferré, S; Fredholm, BB; Fuxe, K; Lillrank, SM; Lipska, BK; Weinberger, DR1

Other Studies

2 other study(ies) available for sch 23982 and raclopride

ArticleYear
Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Synapse (New York, N.Y.), 1998, Volume: 30, Issue:1

    Topics: Animals; Autoradiography; Basal Ganglia; Benzazepines; Dopamine Antagonists; Female; Gene Expression Regulation; Iodine Radioisotopes; Kinetics; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; RNA, Messenger; Salicylamides; Substantia Nigra; Transcription, Genetic

1998
Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
    Neurochemistry international, 1999, Volume: 34, Issue:3

    Topics: Animals; Animals, Newborn; Antipsychotic Agents; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Female; Hippocampus; Male; Pregnancy; Purinergic P1 Receptor Antagonists; Pyrimidines; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Salicylamides; Schizophrenia; Triazoles; Xanthines

1999